Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Dexamethasone sodium phosphate
Eurovet Animal Health B.V.
QH02AB02
Dexamethasone sodium phosphate
2 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
Cats, Cattle, Dogs, Horses, Pigs
dexamethasone
Corticosteroid
Authorised
2008-04-04
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Rapidexon 2 mg/ml solution for injection. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each millilitre contains: ACTIVE SUBSTANCE: Dexamethasone (as Dexamethasone Sodium Phosphate) 2.0 mg EXCIPIENT: Benzyl alcohol (E1519), 15.0 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. A clear colourless solution practically free from particles. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses, cattle, pigs, cats and dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In horses, cattle, pigs, dogs and cats: Treatment of inflammatory or allergic conditions. In cattle: Treatment of primary ketosis (acetonaemia). Induction of parturition In horses: Treatment of arthritis, bursitis or tenosynovitis. I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _3_ _0_ _/_ _0_ _1_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _6_ _4_ _3_ _7_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.3 CONTRAINDICATIONS Except in emergency situations, do not use in animals suffering from diabetes mellitus, renal insufficiency, cardiac insufficiency, hyperadrenocorticism, or osteoporosis. Do not use in viral infections during the viraemic stage or in cases of systemic mycotic infections. Do not use in animals suffering from gastrointestinal or corneal ulcers, or demodicosis. Do not administer intra-articularly where there is evidence of fractures, bacterial joint infections and aseptic bone necrosis. Do not Belgenin tamamını okuyun